Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 20, 2017
The role of urinary KIM-1, NGAL, CA19-9 and β2-microglobulin in the assessment of ureteropelvic junction obstruction in adultsEduardo P Miranda, Ricardo J Duarte, José de Bessa, et al.
Histopathology|January 16, 2023
Interobserver reproducibility of cribriform cancer in prostate needle biopsies and validation of International Society of Urological Pathology criteriaLars Egevad, Brett Delahunt, Kenneth A Iczkowski, et al.
Andrology|July 1, 2021
Testicular pathology in fatal COVID-19: A descriptive autopsy studyAmaro N Duarte-Neto, Thiago A Teixeira, Elia G Caldini, et al.
Molecular Biology Research Communications|September 3, 2021
MiR-200c-3p expression may be associated with worsening of the clinical course of patients with COVID-19Ruan Pimenta, Nayara I Viana, Gabriel A Dos Santos, et al.
Journal of Cancer Research and Clinical Oncology|February 2, 2024
Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progressionRuan Pimenta, Feres Camargo Malulf, Poliana Romão, et al.
Pathology|June 21, 2020
Granular necrosis: a distinctive form of cell death in malignant tumoursHemamali Samaratunga, Brett Delahunt, John R Srigley, et al.
Clinical Genetics|June 17, 2026
The WHO Classification of Genetic Tumour Syndromes: Considerations for GeneticsIan A Cree, Mark J Arends, Joseph D Khoury, et al.
European Urology Open Science|April 20, 2026
Finding Holes: Pathologist-Level Performance Using AI for Cribriform Morphology Detection in Prostate CancerKelvin Szolnoky, Anders Blilie, Nita Mulliqi, et al.
Virchows Archiv : an International Journal of Pathology|June 17, 2020
Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted gradingLars Egevad, Daniela Swanberg, Brett Delahunt, et al.
Pathology|December 18, 2019
Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be gradedHemamali Samaratunga, Brett Delahunt, Lars Egevad, et al.
Pageof 9